{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:32:22Z","timestamp":1775025142441,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the 90th Anniversary of Chulalongkorn University Fund"},{"name":"the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11259-023-10106-0","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:02:54Z","timestamp":1680008574000},"page":"1505-1521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Siriwan","family":"Sakarin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anudep","family":"Rungsipipat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirilak Disatian","family":"Surachetpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"10106_CR1","doi-asserted-by":"crossref","first-page":"1802308","DOI":"10.1183\/13993003.02308-2018","volume":"54","author":"S Abid","year":"2019","unstructured":"Abid S, Marcos E, Parpaleix A, Amsellem V, Breau M, Houssaini A, Vienney N, Lefevre M, Derumeaux G, Evans S, Hubeau C, Delcroix M, Quarck R, Adnot S, Lipskaia L (2019) CCR2\/CCR5-mediated macrophage-smoothmuscle cell crosstalk in pulmonary hypertension. Eur Respir J 54:1802308","journal-title":"Eur Respir J"},{"key":"10106_CR2","doi-asserted-by":"crossref","first-page":"L193","DOI":"10.1152\/ajplung.2000.278.1.L193","volume":"278","author":"IA Akers","year":"2000","unstructured":"IA Akers M Parsons MR Hill MD Hollenberg S Sanjar GJ Laurent  2000 Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2 Am J Physiol Lung Cell Mol Physiol 278 L193 201","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10106_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/rcmb.2016-0201OC","volume":"56","author":"V Amsellem","year":"2017","unstructured":"V Amsellem S Abid L Poupel A Parpaleix M Rodero G Gary-Bobo  2017 Roles for the CX3CL1\/CX3CR1 and CCL2\/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension Am J Respir Cell Mol Biol 56 597 608","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10106_CR4","first-page":"229","volume-title":"Muscle Cell and Tissue Current Status of Research Field","author":"L Bacakova","year":"2018","unstructured":"L Bacakova M Travnickova E Filova R Mat\u011bjka J Stepanovska J Musilkova  2018 The role of vascular smooth muscle cells in the physiology and pathophysiology of blood vessels K Sakuma Eds Muscle Cell and Tissue Current Status of Research Field IntechOpen UK 229 257"},{"key":"10106_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/ijmm.2013.1591","volume":"33","author":"Y Bai","year":"2014","unstructured":"Y Bai HM Wang M Liu Y Wang GC Lian XH Zhang  2014 4-Chloro-DL-phenylalanine protects against monocrotaline-induced pulmonary vascular remodeling and lung inflammation Int J Mol Med 33 373 382","journal-title":"Int J Mol Med"},{"key":"10106_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000121410","volume":"76","author":"A Ba\u0148asov\u00e1","year":"2008","unstructured":"A Ba\u0148asov\u00e1 H Maxov\u00e1 V Hampl M V\u00edzek V Pov\u00fd\u0161ilov\u00e1 J Novotn\u00e1  2008 Prevention of Mast Cell Degranulation by Disodium Cromoglycate Attenuates the Development of Hypoxic Pulmonary Hypertension in Rats Exposed to Chronic Hypoxia Respiration 76 102 107","journal-title":"Respiration"},{"key":"10106_CR7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1378\/chest.11-0663","volume":"141","author":"B Bartelds","year":"2012","unstructured":"B Bartelds RLE Loon Van S Mohaupt H Wijnberg MG Dickinson B Boersma  2012 Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension Chest 141 651 660","journal-title":"Chest"},{"key":"10106_CR8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","volume":"190","author":"MO Becker","year":"2014","unstructured":"MO Becker A Kill M Kutsche J Guenther A Rose C Tabeling  2014 Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis Am J Respir Crit Care Med 190 808 817","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/jvim.12564","volume":"29","author":"M Borgarelli","year":"2015","unstructured":"M Borgarelli J Abbott L Braz-Ruivo D Chiavegato S Crosara K Lamb  2015 Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease J Vet Intern Med 29 569 574","journal-title":"J Vet Intern Med"},{"key":"10106_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1760-2734(06)70055-8","volume":"6","author":"M Borgarelli","year":"2004","unstructured":"M Borgarelli E Zini G D'agnolo A Tarducci RA Santilli D Chiavegato  2004 Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds J Vet Cardiol 6 27 34","journal-title":"J Vet Cardiol"},{"key":"10106_CR11","doi-asserted-by":"crossref","first-page":"L710","DOI":"10.1152\/ajplung.00311.2016","volume":"312","author":"S Breitling","year":"2017","unstructured":"S Breitling Z Hui D Zabini Y Hu J Hoffmann NM Goldenberg  2017 The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 312 L710 l721","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10106_CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fimmu.2015.00394","volume":"6","author":"S Bulfone-Paus","year":"2015","unstructured":"S Bulfone-Paus R Bahri 2015 Mast Cells as Regulators of T Cell Responses Front Immunol 6 394","journal-title":"Front Immunol"},{"key":"10106_CR13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/annrheumdis-2011-200195","volume":"71","author":"G Bussone","year":"2012","unstructured":"G Bussone MC Tamby C Calzas N Kherbeck Y Sahbatou C Sanson  2012 IgG from patients with pulmonary arterial hypertension and\/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction Ann Rheum Dis 71 596 605","journal-title":"Ann Rheum Dis"},{"key":"10106_CR14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12931-019-1003-4","volume":"20","author":"E Caglayan","year":"2019","unstructured":"E Caglayan M Trappiel A Behringer EM Berghausen M Odenthal E Wellnhofer  2019 Pulmonary arterial remodelling by deficiency of peroxisome proliferator-activated receptor-\u03b3 in murine vascular smooth muscle cells occurs independently of obesity-related pulmonary hypertension Respir Res 20 42","journal-title":"Respir Res"},{"key":"10106_CR15","doi-asserted-by":"crossref","unstructured":"JL Caswell, KJ Williams (2016) Respiratory System. In:  Maxie MG, Saunders WB (eds) Jubb, Kennedy and Palmer's Pathology of Domestic Animals: Volume 2, 6th edn. pp 465\u2013591","DOI":"10.1016\/B978-0-7020-5318-4.00011-5"},{"key":"10106_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000232738","volume":"65","author":"JP Chandler","year":"1981","unstructured":"JP Chandler TJ Yang 1981 Identification of canine lymphocyte populations by immunofluorescence surface marker analysis Int Arch Allergy Appl Immunol 65 62 68","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10106_CR17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00.15111600","volume":"15","author":"I Chazova","year":"2000","unstructured":"I Chazova I Robbins J Loyd J Newman V Tapson V Zhdaov  2000 Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis Eur Respir J 15 116 122","journal-title":"Eur Respir J"},{"key":"10106_CR18","volume":"88","author":"S Chen","year":"2020","unstructured":"S Chen D Yan A Qiu 2020 The role of macrophages in pulmonary hypertension: Pathogenesis and targeting Int Immunopharmacol 88 106934","journal-title":"Int Immunopharmacol"},{"key":"10106_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1740-8261.2009.01529.x","volume":"50","author":"D Chiavegato","year":"2009","unstructured":"D Chiavegato M Borgarelli G D'agnolo RA Santilli 2009 Pulmonary hypertension in dogs with mitral regurgitation attributable to myxomatous valve disease Vet Radiol Ultrasound 50 253 258","journal-title":"Vet Radiol Ultrasound"},{"key":"10106_CR20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V67.6.1600.1600","volume":"67","author":"P Clark","year":"1986","unstructured":"P Clark DE Normansell DJ Innes CE Hess 1986 Lymphocyte Subsets in Normal Bone Marrow Blood 67 1600 1606","journal-title":"Blood"},{"key":"10106_CR21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1164\/rccm.201302-0403OC","volume":"188","author":"KL Colvin","year":"2013","unstructured":"KL Colvin PJ Cripe DD Ivy KR Stenmark ME Yeager 2013 Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies Am J Respir Crit Care Med 188 1126 1136","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2009-0365OC","volume":"45","author":"MJ Cuttica","year":"2011","unstructured":"MJ Cuttica T Langenickel A Noguchi RF Machado MT Gladwin M Boehm 2011 Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage Am J Respir Cell Mol Biol 45 62 71","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10106_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1465-9921-12-60","volume":"12","author":"BK Dahal","year":"2011","unstructured":"BK Dahal D Kosanovic C Kaulen T Cornitescu R Savai J Hoffmann  2011 Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats Respir Res 12 60","journal-title":"Respir Res"},{"key":"10106_CR24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejheart.2004.10.021","volume":"7","author":"JF Delgado","year":"2005","unstructured":"JF Delgado E Conde V Sanchez F Lopez-Rios MA Gomez-Sanchez P Escribano  2005 Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure Eur J Heart Fail 7 1011 1016","journal-title":"Eur J Heart Fail"},{"key":"10106_CR25","first-page":"402","volume":"17","author":"S Disatian","year":"2008","unstructured":"S Disatian EJ Ehrhart S Zimmerman EC Orton 2008 Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation J Heart Valve Dis 17 402 411","journal-title":"J Heart Valve Dis"},{"key":"10106_CR26","first-page":"71","volume":"19","author":"S Disatian","year":"2010","unstructured":"S Disatian C Lacerda EC Orton 2010 Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves J Heart Valve Dis 19 71 78","journal-title":"J Heart Valve Dis"},{"key":"10106_CR27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","volume":"22","author":"P Dorfm\u00fcller","year":"2003","unstructured":"P Dorfm\u00fcller F Perros K Balabanian M Humbert 2003 Inflammation in pulmonary arterial hypertension Eur Respir J 22 358 363","journal-title":"Eur Respir J"},{"key":"10106_CR28","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.1701287","volume":"200","author":"J Florentin","year":"2018","unstructured":"J Florentin E Coppin SB Vasamsetti J Zhao YY Tai Y Tang  2018 Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes J Immunol 200 3612 3625","journal-title":"J Immunol"},{"key":"10106_CR29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","volume":"168","author":"MG Frid","year":"2006","unstructured":"MG Frid JA Brunetti DL Burke TC Carpenter NJ Davie JT Reeves  2006 Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage Am J Pathol 168 659 669","journal-title":"Am J Pathol"},{"key":"10106_CR30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1164\/rccm.201903-0591OC","volume":"201","author":"MG Frid","year":"2020","unstructured":"MG Frid BA Mckeon JM Thurman BA Maron M Li H Zhang  2020 Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension Am J Respir Crit Care Med 201 224 239","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-1653","volume":"143","author":"C Gerges","year":"2013","unstructured":"C Gerges M Gerges MB Lang Y Zhang J Jakowitsch P Probst  2013 Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in \"out-of-proportion\" pulmonary hypertension Chest 143 758 766","journal-title":"Chest"},{"key":"10106_CR32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.mpdhp.2019.05.002","volume":"25","author":"M-R Ghigna","year":"2019","unstructured":"M-R Ghigna P Dorfm\u00fcller 2019 Pulmonary vascular disease and pulmonary hypertension Diagn Histopathol 25 304 312","journal-title":"Diagn Histopathol"},{"key":"10106_CR33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09059180.00004612","volume":"21","author":"M Guazzi","year":"2012","unstructured":"M Guazzi N Gali\u00e8 2012 Pulmonary hypertension in left heart disease Eur Respir Rev 21 338 346","journal-title":"Eur Respir Rev"},{"key":"10106_CR34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1939-1676.2009.0430.x","volume":"24","author":"C Guglielmini","year":"2010","unstructured":"C Guglielmini C Civitella A Diana M Tommaso Di M Cipone A Luciani 2010 Serum cardiac troponin I concentration in dogs with precapillary and postcapillary pulmonary hypertension J Vet Intern Med 24 145 152","journal-title":"J Vet Intern Med"},{"key":"10106_CR35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0033-1356496","volume":"34","author":"C Guignabert","year":"2013","unstructured":"C Guignabert P Dorfmuller 2013 Pathology and pathobiology of pulmonary hypertension Semin Respir Crit Care Med 34 551 559","journal-title":"Semin Respir Crit Care Med"},{"key":"10106_CR36","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1183\/09031936.00043310","volume":"37","author":"J Hoffmann","year":"2011","unstructured":"J Hoffmann J Yin M Kukucka N Yin I Saarikko A Sterner-Kock  2011 Mast cells promote lung vascular remodelling in pulmonary hypertension Eur Respir J 37 1400 1410","journal-title":"Eur Respir J"},{"key":"10106_CR37","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/cells9112338","volume":"9","author":"Y Hu","year":"2020","unstructured":"Y Hu L Chi WM Kuebler NM Goldenberg 2020 Perivascular Inflammation in Pulmonary Arterial Hypertension Cells 9 2338","journal-title":"Cells"},{"key":"10106_CR38","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","volume":"53","author":"M Humbert","year":"2019","unstructured":"M Humbert C Guignabert S Bonnet P Dorfm\u00fcller JR Klinger MR Nicolls  2019 Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Eur Respir J 53 1801887","journal-title":"Eur Respir J"},{"key":"10106_CR39","doi-asserted-by":"crossref","first-page":"L725","DOI":"10.1152\/ajplung.00186.2013","volume":"305","author":"JM Hunt","year":"2013","unstructured":"JM Hunt B Bethea X Liu A Gandjeva PPA Mammen E Stacher  2013 Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease Am J Physiol Lung Cell Mol Physiol 305 L725 L736","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10106_CR40","volume-title":"Veterinary Histology","author":"R Jennings","year":"2017","unstructured":"R Jennings C Premanandan 2017 Veterinary Histology Ohio State University Libraries"},{"key":"10106_CR41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Keene","year":"2019","unstructured":"BW Keene CE Atkins JD Bonagura PR Fox J H\u00e4ggstr\u00f6m VL Fuentes  2019 ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs J Vet Intern Med 33 1127 1140","journal-title":"J Vet Intern Med"},{"key":"10106_CR42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cvsm.2010.03.011","volume":"40","author":"HB Kellihan","year":"2010","unstructured":"HB Kellihan RL Stepien 2010 Pulmonary hypertension in dogs: diagnosis and therapy Vet Clin North Am Small Anim Pract 40 623 641","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10106_CR43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jvc.2012.01.001","volume":"14","author":"HB Kellihan","year":"2012","unstructured":"HB Kellihan RL Stepien 2012 Pulmonary hypertension in canine degenerative mitral valve disease J Vet Cardiol 14 149 164","journal-title":"J Vet Cardiol"},{"key":"10106_CR44","doi-asserted-by":"crossref","first-page":"204589321875759","DOI":"10.1177\/2045893218757596","volume":"8","author":"WM Kuebler","year":"2018","unstructured":"WM Kuebler S Bonnet A Tabuchi 2018 Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series) Pulm Circ 8 2045893218757596 2045893218757596","journal-title":"Pulm Circ"},{"key":"10106_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/biomedicines9010057","volume":"9","author":"K Kurakula","year":"2021","unstructured":"K Kurakula VFED Smolders O Tura-Ceide JW Jukema PHA Quax M-J Goumans 2021 Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence? Biomedicines 9 57","journal-title":"Biomedicines"},{"key":"10106_CR46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/CIRCRESAHA.111.257568","volume":"110","author":"G Kwapiszewska","year":"2012","unstructured":"G Kwapiszewska P Markart BK Dahal B Kojonazarov LM Marsh RT Schermuly  2012 PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension Circ Res 110 1179 1191","journal-title":"Circ Res"},{"key":"10106_CR47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jacc.2006.09.049","volume":"49","author":"M L\u00e9vy","year":"2007","unstructured":"M L\u00e9vy C Maurey DS Celermajer PR Vouh\u00e9 C Danel D Bonnet  2007 Impaired Apoptosis of Pulmonary Endothelial Cells Is Associated With Intimal Proliferation and Irreversibility of Pulmonary Hypertension in Congenital Heart Disease J Am Coll Cardiol 49 803 810","journal-title":"J Am Coll Cardiol"},{"key":"10106_CR48","first-page":"10139","volume":"9","author":"C Li","year":"2016","unstructured":"C Li J Feng L Cai Li M Yan W Ying Wei F Jing  2016 Muscularization of Pulmonary Artery and RhoA\/ROCK levels in Rats Exposed to Intermittent Hypoxia Int J Clin Exp Pathol 9 10139 10148","journal-title":"Int J Clin Exp Pathol"},{"key":"10106_CR49","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4049\/jimmunol.1100479","volume":"187","author":"M Li","year":"2011","unstructured":"M Li SR Riddle MG Frid KC Kasmi El TA Mckinsey RJ Sokol  2011 Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension J Immunol 187 2711 2722","journal-title":"J Immunol"},{"key":"10106_CR50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1742-7843.2012.00933.x","volume":"112","author":"M Liu","year":"2013","unstructured":"M Liu Y Wang HM Wang Y Bai XH Zhang YX Sun  2013 Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor Basic Clin Pharmacol Toxicol 112 77 82","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10106_CR51","doi-asserted-by":"crossref","unstructured":"R Mathew R (2020) Endothelial Dysfunction and Disruption in Pulmonary Hypertension. In: Abukabda A, Suciu M, Andor MM (eds) Cardiovascular Risk Factors in Pathology. IntechOpen, pp 92177","DOI":"10.5772\/intechopen.92177"},{"key":"10106_CR52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000312403","volume":"80","author":"H Maxov\u00e1","year":"2010","unstructured":"H Maxov\u00e1 M Vasilkov\u00e1 J Novotn\u00e1 O Vajnerov\u00e1 A Bansov\u00e1 M V\u00edzek  2010 Prevention of mast cell degranulation by disodium cromoglycate delayed the regression of hypoxic pulmonary hypertension in rats Respiration 80 335 339","journal-title":"Respiration"},{"key":"10106_CR53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","volume":"12","author":"C Medrek","year":"2012","unstructured":"C Medrek F Pont\u00e9n K Jirstr\u00f6m K Leandersson 2012 The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients BMC Cancer 12 306","journal-title":"BMC Cancer"},{"key":"10106_CR54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.201006-0905OC","volume":"184","author":"D Montani","year":"2011","unstructured":"D Montani F Perros N Gambaryan B Girerd P Dorfmuller LC Price  2011 C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 184 116 123","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR55","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","volume":"102","author":"DL Moraes","year":"2000","unstructured":"DL Moraes WS Colucci MM Givertz 2000 Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management Circulation 102 1718 1723","journal-title":"Circulation"},{"key":"10106_CR56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152987","volume":"11","author":"M Mu\u00f1oz-Esquerre","year":"2016","unstructured":"M Mu\u00f1oz-Esquerre M L\u00f3pez-S\u00e1nchez I Escobar D Huertas R Pen\u00edn M Molina-Molina  2016 Systemic and pulmonary vascular remodelling in chronic obstructive pulmonary disease PLOS ONE 11 e0152987","journal-title":"PLOS ONE"},{"key":"10106_CR57","volume":"3","author":"H Patel","year":"2014","unstructured":"H Patel M Desai EM Tuzcu B Griffin S Kapadia 2014 Pulmonary hypertension in mitral regurgitation J Am Heart Assoc 3 e000748","journal-title":"J Am Heart Assoc"},{"key":"10106_CR58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","volume":"185","author":"F Perros","year":"2012","unstructured":"F Perros P Dorfm\u00fcller D Montani H Hammad W Waelput B Girerd  2012 Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 185 311 321","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.carpath.2004.06.003","volume":"13","author":"RF Pinto","year":"2004","unstructured":"RF Pinto L Higuchi Mde VD Aiello 2004 Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts Cardiovasc Pathol 13 268 275","journal-title":"Cardiovasc Pathol"},{"key":"10106_CR60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.11-0793","volume":"141","author":"LC Price","year":"2012","unstructured":"LC Price SJ Wort F Perros P Dorfm\u00fcller A Huertas D Montani  2012 Inflammation in pulmonary arterial hypertension Chest 141 210 221","journal-title":"Chest"},{"key":"10106_CR61","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.4049\/jimmunol.1601692","volume":"198","author":"SC Pugliese","year":"2017","unstructured":"SC Pugliese S Kumar WJ Janssen BB Graham MG Frid SR Riddle  2017 A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension J Immunol 198 4802 4812","journal-title":"J Immunol"},{"key":"10106_CR62","doi-asserted-by":"crossref","first-page":"L641","DOI":"10.1152\/ajplung.2000.279.4.L641","volume":"279","author":"TR Quinlan","year":"2000","unstructured":"TR Quinlan D Li VE Laubach EG Shesely N Zhou RA Johns 2000 eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia Am J Physiol Lung Cell Mol Physiol 279 L641 650","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10106_CR63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"M Rabinovitch C Guignabert M Humbert MR Nicolls 2014 Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Circ Res 115 165 175","journal-title":"Circ Res"},{"key":"10106_CR64","doi-asserted-by":"crossref","first-page":"204589321775291","DOI":"10.1177\/2045893217752912","volume":"8","author":"B Ranchoux","year":"2018","unstructured":"B Ranchoux LD Harvey RJ Ayon A Babicheva S Bonnet SY Chan  2018 Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series) Pulm Circ 8 2045893217752912","journal-title":"Pulm Circ"},{"key":"10106_CR65","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jvim.15725","volume":"34","author":"C Reinero","year":"2020","unstructured":"C Reinero LC Visser HB Kellihan I Masseau E Rozanski C Clercx  2020 ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs J Vet Intern Med 34 549 573","journal-title":"J Vet Intern Med"},{"key":"10106_CR66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jvc.2021.06.005","volume":"36","author":"S Sakarin","year":"2021","unstructured":"S Sakarin A Rungsipipat SD Surachetpong 2021 Histopathological changes of pulmonary vascular remodeling in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease J Vet Cardiol 36 141 152","journal-title":"J Vet Cardiol"},{"key":"10106_CR67","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","volume":"186","author":"R Savai","year":"2012","unstructured":"R Savai SS Pullamsetti J Kolbe E Bieniek R Voswinckel L Fink  2012 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 186 897 908","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR68","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.RES.0000126050.41296.8E","volume":"94","author":"RT Schermuly","year":"2004","unstructured":"RT Schermuly KP Kreisselmeier HA Ghofrani A Samidurai S Pullamsetti N Weissmann  2004 Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3\/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension Circ Res 94 1101 1108","journal-title":"Circ Res"},{"key":"10106_CR69","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1939-1676.2010.0592.x","volume":"24","author":"KE Schober","year":"2010","unstructured":"KE Schober TM Hart JA Stern X Li VF Samii LJ Zekas  2010 Detection of congestive heart failure in dogs by Doppler echocardiography J Vet Intern Med 24 1358 1368","journal-title":"J Vet Intern Med"},{"key":"10106_CR70","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.2460\/javma.229.11.1772","volume":"229","author":"FJ Serres","year":"2006","unstructured":"FJ Serres V Chetboul R Tissier C Carlos Sampedrano V Gouni AP Nicolle  2006 Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001\u20132005) J Am Vet Med Assoc 229 1772 1778","journal-title":"J Am Vet Med Assoc"},{"key":"10106_CR71","doi-asserted-by":"crossref","first-page":"H677","DOI":"10.1152\/ajpheart.91519.2007","volume":"295","author":"Y Song","year":"2008","unstructured":"Y Song L Coleman J Shi H Beppu K Sato K Walsh  2008 Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice Am J Physiol Heart Circ Physiol 295 H677 690","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10106_CR72","volume-title":"Gray's Anatomy: The Anatomical Basis of Clinical Practice","author":"S Standring","year":"2020","unstructured":"S Standring 2020 Gray's Anatomy: The Anatomical Basis of Clinical Practice Elsevier"},{"key":"10106_CR73","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1164\/rccm.200608-1189OC","volume":"175","author":"L Taraseviciene-Stewart","year":"2007","unstructured":"L Taraseviciene-Stewart MR Nicolls D Kraskauskas R Scerbavicius N Burns C Cool  2007 Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling Am J Respir Crit Care Med 175 1280 1289","journal-title":"Am J Respir Crit Care Med"},{"key":"10106_CR74","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cphy.c100081","volume":"2","author":"MI Townsley","year":"2012","unstructured":"MI Townsley 2012 Structure and composition of pulmonary arteries, capillaries, and veins Compr Physiol 2 675 709","journal-title":"Compr Physiol"},{"key":"10106_CR75","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.110.978627","volume":"123","author":"E Vergadi","year":"2011","unstructured":"E Vergadi MS Chang C Lee OD Liang X Liu A Fernandez-Gonzalez  2011 Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension Circulation 123 1986 1995","journal-title":"Circulation"},{"key":"10106_CR76","first-page":"3836","volume":"7","author":"HL Wang","year":"2014","unstructured":"HL Wang LP Peng WJ Chen SH Tang BZ Sun CL Wang  2014 HMGB1 enhances smooth muscle cell proliferation and migration in pulmonary artery remodeling Int J Clin Exp Pathol 7 3836 3844","journal-title":"Int J Clin Exp Pathol"},{"key":"10106_CR77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-014-0148-4","volume":"15","author":"PS Yang","year":"2014","unstructured":"PS Yang DH Kim YJ Lee SE Lee WJ Kang HJ Chang  2014 Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats Respir Res 15 148","journal-title":"Respir Res"},{"key":"10106_CR78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12931-016-0478-5","volume":"17","author":"IN Zelko","year":"2016","unstructured":"IN Zelko J Zhu JD Ritzenthaler J Roman 2016 Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica Respir Res 17 160","journal-title":"Respir Res"},{"key":"10106_CR79","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1440-1681.2009.05168.x","volume":"36","author":"FG Zhai","year":"2009","unstructured":"FG Zhai XH Zhang HL Wang 2009 Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats Clin Exp Pharmacol Physiol 36 850 856","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-023-10106-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-023-10106-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-023-10106-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T11:18:03Z","timestamp":1694085483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-023-10106-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10106"],"URL":"https:\/\/doi.org\/10.1007\/s11259-023-10106-0","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were waived for this study due to the study was performed on donated cadavers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of animal ethics"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}